Lexeo Therapeutics (NASDAQ:LXEO) Given “Outperform” Rating at Royal Bank of Canada
Royal Bank of Canada restated their outperform rating on shares of Lexeo Therapeutics (NASDAQ:LXEO – Free Report) in a report published on Tuesday morning,Benzinga reports. Royal Bank of Canada ...
Brokerages Set Zura Bio Limited (NASDAQ:ZURA) PT at $15.80
Zura Bio Limited (NASDAQ:ZURA – Get Free Report) has been given an average rating of “Buy” by the seven ratings firms that ...
Allurion secures new patent for gastric balloon technology
NATICK, Mass. - Allurion Technologies, Inc. (NYSE: ALUR), a company focused on obesity treatment solutions, has expanded its ...
DFLI stock touches 52-week low at $2.49 amid market challenges
In a challenging market environment, DFLI, the stock for Chardan Nextech Acquisition 2, has reached a 52-week low, dipping to $2.49. According to InvestingPro analysis, the company's financial health ...